Cytodyn Inc (CYDY)

[misiu143]

CytoDyn's cancer asset leronlimab likely to advance after basket trial complation..

--Any day we should have results from the study in MD Anderson ,
Check point inhibitors with leronlimab ..
Since leronlimab is also downregulating check points , I am not sure if combination with some others will be beneficial , but it should show how good leronlimab is ..

-- And using leronlimab in CAR-T treatment in one of the university in Boston , should be VERY impressive for leronlimab.
Not only that efficacy in cancer treatment should improve , but the severe side effects with CAR-T treatment , sometimes deadly , happening in about 50% of treating patients , " Cytokine Release Syndrome " I will expect to be remove or reduced with leronlmab..

-- And study going on in NYC , leronlimab treating glioblastoma , should have impressive results ...

https://www.clinicaltrialsarena.com/analysis/regulatory-roundup-cytodyns-cancer-asset-leronlimab-likely-to-advance-after-basket-trial-completion/
Updated July 2022.

All imo.

GLTA longs.